LMAO I'm guessing CJ is not agreeing.
Just to clarify, the licence that restricts our production is a lanthanide processing limit, it's separate to our import licence. Anyway, I re-visited my post from 2021 (Post #: 53360805) and expanded to include the last couple of years. This chart illustrates our production limit history:
(each rectangle in the chart represents a calendar year (CY). Red line illustrates average NdPr production for the CY)
CY2017-2019 we pushed our production in the early quarters, only to be forced to shutdown or slow down so we didn't exceed the processing limit. Twice in this period our applications to increase the limit was denied.
CY2020-2021 by this time we had learned our lesson from previous years, and the aim was to run a more steady rate through the four quarters (minus covid).
CY2022-present Fluctuations have been pretty wild. Our processing limit is still in place, but water issues + quota carried forward from the covid quarter has allowed us to put the pedal to the metal at times. In addition, we have improved overall recoveries, and prioritised NdPr recovery specifically the past couple of years.
Main point is, we have had the capacity to go at NEXT, just not the regulatory approvals to do so. We likely stopped applying for an uplift as it becomes irrelevant once we have shifted to Kal carbonate.
It's quite amusing knowing CJ have wasted time the past three years posting charts and comments arguing otherwise. Utter waste of time.
PS everything is the chart, numbers and comments, are all sourced from LYC.
- Forums
- ASX - By Stock
- LYC
- NdPR price
NdPR price, page-2471
-
- There are more pages in this discussion • 186 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$7.72 |
Change
0.310(4.18%) |
Mkt cap ! $7.216B |
Open | High | Low | Value | Volume |
$7.46 | $7.74 | $7.46 | $15.65M | 2.044M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 14728 | $7.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.73 | 4250 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14728 | 7.700 |
3 | 12697 | 7.680 |
2 | 33352 | 7.660 |
3 | 20303 | 7.650 |
2 | 3386 | 7.640 |
Price($) | Vol. | No. |
---|---|---|
7.730 | 4250 | 2 |
7.740 | 3000 | 2 |
7.750 | 11369 | 6 |
7.770 | 14611 | 2 |
7.780 | 19811 | 2 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online